Keay Nakae
Director of Research Chardan
Seminars
Thursday 31st July 2025
Investment Panel: Attracting Investment & Securing Preclinical Funding for Early-Stage RNA Editing Therapeutic Candidates
9:00 am
• How is RNA editing viewed by investors and what are the directions for growth?
• How to successfully gain funding for preclinical candidates by demonstrating the right data
• What are the hurdles and pitfalls to starting an RNA Editing therapeutics company and what are the timelines, collaborations, and levels of investment required
